Position in ILMN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,947,328
+$1,687,349 QoQ
Shares Held
28,137
+6.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#250
of 932 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $85,439,394 across 8 Diagnostics & Research names. ILMN ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
158,423 | $30,176,413 | |
| 2 | LH |
Labcorp Holdings Inc.
|
85,568 | $23,959,040 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
43,021 | $21,569,008 | |
| 4 | ILMN |
Illumina, Inc.
This page
|
28,137 | $4,947,328 | |
| 5 | VCYT |
Veracyte, Inc.
|
62,229 | $3,654,709 | |
| 6 | MYGN |
Myriad Genetics Inc
|
81,392 | $464,748 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,494 | $464,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,056 | $204,040 |
All Filings in ILMN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,947,328 | 28,137 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,259,979 | 26,448 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,241,094 | 24,711 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,341,485 | 24,655 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,338,689 | 24,512 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,920,900 | 24,211 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,101,552 | 23,210 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,924,313 | 22,424 | Shares | Sole | 2024-11-14 | |
| 2021-09-30 | $330,977 | 816 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,711,537 | 14,183 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||